This review highlights the importance of standardized stroke definitions and careful endpoint selection when evaluating neuroprotective devices to mitigate peri-procedural stroke risk during TAVI.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Ghare et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: